These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2856654)

  • 1. Central nervous system action of TRH to stimulate gastric function and ulceration.
    Taché Y; Maeda-Hagiwara M; Goto Y; Garrick T
    Peptides; 1988; 9 Suppl 1():9-13. PubMed ID: 2856654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system action of TRH to influence gastrointestinal function and ulceration.
    Taché Y; Stephens RL; Ishikawa T
    Ann N Y Acad Sci; 1989; 553():269-85. PubMed ID: 2497674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent central nervous system action of p-Glu-His-(3,3'-dimethyl)-Pro NH2, a stabilized analog of TRH, to stimulate gastric secretion in rats.
    Taché Y; Goto Y; Lauffenburger M; Lesiege D
    Regul Pept; 1984 Jan; 8(1):71-8. PubMed ID: 6425995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central action of TRH to induce vagally mediated gastric cytoprotection and ulcer formation in rats.
    Taché Y; Yoneda M
    J Clin Gastroenterol; 1993; 17 Suppl 1():S58-63. PubMed ID: 8283016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system action of thyrotropin-releasing hormone to increase gastric mucosal blood flow in the rat.
    Thiefin G; Taché Y; Leung FW; Guth PH
    Gastroenterology; 1989 Aug; 97(2):405-11. PubMed ID: 2501141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracisternal thyrotropin-releasing hormone-induced vagally mediated gastric protection against ethanol lesions: central and peripheral mechanisms.
    Taché Y; Yoneda M; Kato K; Király A; Sütö G; Kaneko H
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S29-35. PubMed ID: 7881015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement by intracerebroventricular thyrotropin-releasing hormone of indomethacin-induced gastric lesions in the rat.
    Maeda-Hagiwara M; Watanabe H; Watanabe K
    Br J Pharmacol; 1983 Dec; 80(4):735-9. PubMed ID: 6443756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric erosions induced by intracisternal thyrotropin-releasing hormone (TRH) in rats.
    Goto Y; Tache Y
    Peptides; 1985; 6(1):153-6. PubMed ID: 3921944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine pretreatment potentiates intracisternal TRH analogue-stimulated gastric acid secretion in rats.
    Shockley RA; LePard KJ; Stephens RL
    Regul Pept; 1992 Mar; 38(2):121-8. PubMed ID: 1574606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone: medullary site of action to induce gastric ulcers and stimulate acid secretion.
    Hernandez DE; Emerick SG
    Brain Res; 1988 Aug; 459(1):148-52. PubMed ID: 3139260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular injection of a TRH analogue, gamma-butyrolactone-gamma-carbonyl-L-histidyl-prolinamide, induces gastric lesions and gastric acid stimulation in rats.
    Maeda-Hagiwara M; Watanabe H
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):142-6. PubMed ID: 3930976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone (TRH) acts centrally to stimulate gastric contractility in rats.
    Garrick T; Buack S; Veiseh A; Tache Y
    Life Sci; 1987 Feb; 40(7):649-57. PubMed ID: 3100898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary sites of action of the TRH analogue, RX 77368, for stimulation of gastric acid secretion in the rat.
    Ishikawa T; Yang H; Taché Y
    Gastroenterology; 1988 Dec; 95(6):1470-6. PubMed ID: 3141237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vagus-mediated activation of mucosal mast cells in the stomach: effect of ketotifen on gastric mucosal lesion formation and acid secretion induced by a high dose of intracisternal TRH analogue.
    Király A; Süto G; Tam B; Hermann V; Mózsik G
    J Physiol Paris; 2000; 94(2):131-4. PubMed ID: 10791694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific formation of thyrotropin-releasing hormone-induced gastric ulcers through the vagal system.
    Okumura T; Uehara A; Watanabe Y; Taniguchi Y; Kitamori S; Namiki M
    Scand J Gastroenterol; 1994 Mar; 29(3):226-31. PubMed ID: 8209181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracisternal injection of a TRH analogue stimulates gastric luminal serotonin release in rats.
    Stephens RL; Tache Y
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G377-83. PubMed ID: 2493198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system action of TRH to stimulate gastric emptying in rats.
    Maeda-Hagiwara M; Taché Y
    Regul Pept; 1987 Apr; 17(4):199-207. PubMed ID: 3108965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central thyrotropin-releasing factor analog prevents ethanol-induced gastric damage through prostaglandins in rats.
    Yoneda M; Taché Y
    Gastroenterology; 1992 May; 102(5):1568-74. PubMed ID: 1568566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of indomethacin and nabumetone on prostaglandin-mediated gastric responses to central vagal activation in rats.
    Cardin S; Soll AH; Taché Y
    J Pharmacol Exp Ther; 1995 Nov; 275(2):667-73. PubMed ID: 7473153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine prevents gastric lesions induced by centrally administered thyrotropin-releasing hormone (TRH) in rats.
    Hernandez DE; Arredondo ME; Xue BG
    Neurosci Lett; 1990 Apr; 111(3):339-43. PubMed ID: 2159606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.